Literature DB >> 14566830

Relative risk of prostate cancer for men with affected relatives: systematic review and meta-analysis.

Deborah Watkins Bruner1, Dirk Moore, Alicia Parlanti, Joanne Dorgan, Paul Engstrom.   

Abstract

An increased risk of prostate cancer associated with a family history of prostate cancer has been documented in multiple published reports. Risk has been shown to vary by degree of relationship and age of onset of disease in the affected relative. Several studies, using various designs, have estimated the relative risk (RR) for these associations. The purpose of our study was to identify and summarize published reports on the relationship between risk of prostate cancer and family history, which is defined as having a father, brother, any first- or second-degree relative or other relative affected with prostate cancer. A Medline and manual search from 1982 to 2000 identified 24 studies that reported RR and confidence intervals (CI) and satisfied inclusion criteria. Pooled RR estimates based upon a weighted average model were as follows: any affected family member RR = 1.93, CI 1.65-2.26; affected first-degree relative RR = 2.22, CI 2.06-2.40; affected second-degree relative RR = 1.88, CI 1.54-2.30; father with prostate cancer RR = 2.12, CI 1.82-2.51; and brother with prostate cancer RR = 2.87, CI 2.21-3.73). Statistical comparison of pooled data demonstrated that the RR is significantly higher for affected brother than for affected father (p < 0.03). A sensitivity analysis demonstrated that these results are robust with respect to population bias. This meta-analysis confirms that risk of prostate cancer is associated with family history of disease and improves the quantification of this risk. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2003        PMID: 14566830     DOI: 10.1002/ijc.11466

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  49 in total

1.  Analysis of the gene coding for the BRCA2-interacting protein PALB2 in hereditary prostate cancer.

Authors:  Marc Tischkowitz; Nelly Sabbaghian; Anna M Ray; Ethan M Lange; William D Foulkes; Kathleen A Cooney
Journal:  Prostate       Date:  2008-05-01       Impact factor: 4.104

2.  The Duffy Antigen/Receptor for Chemokines (DARC) and prostate-cancer risk among Jamaican men.

Authors:  Joshua K Elson; Jennifer L Beebe-Dimmer; Hal Morgenstern; Mahdavi Chilkuri; John Blanchard; Alex B Lentsch
Journal:  J Immigr Minor Health       Date:  2011-02

3.  Prostate cancer risk in men with prostate and breast cancer family history: results from the REDUCE study (R1).

Authors:  J-A Thomas; L Gerber; D M Moreira; R J Hamilton; L L Bañez; R Castro-Santamaria; G L Andriole; W B Isaacs; J Xu; S J Freedland
Journal:  J Intern Med       Date:  2012-01-16       Impact factor: 8.989

4.  Genetic Hitchhiking and Population Bottlenecks Contribute to Prostate Cancer Disparities in Men of African Descent.

Authors:  Sarah A Tishkoff; Timothy R Rebbeck; Joseph Lachance; Ali J Berens; Matthew E B Hansen; Andrew K Teng
Journal:  Cancer Res       Date:  2018-02-08       Impact factor: 12.701

5.  Testing for the recurrent HOXB13 G84E germline mutation in men with clinical indications for prostate biopsy.

Authors:  Florian R Schroeck; Kimberly A Zuhlke; Javed Siddiqui; Rabia Siddiqui; Kathleen A Cooney; John T Wei
Journal:  J Urol       Date:  2012-10-02       Impact factor: 7.450

6.  Substantial family history of prostate cancer in black men recruited for prostate cancer screening: results from the Prostate Cancer Risk Assessment Program.

Authors:  Kathleen Mastalski; Elliot J Coups; Karen Ruth; Susan Raysor; Veda N Giri
Journal:  Cancer       Date:  2008-11-01       Impact factor: 6.860

7.  The impact of a family history of prostate cancer on the prognosis and features of the disease in Korea: results from a cross-sectional longitudinal pilot study.

Authors:  Kwang Suk Lee; Kyo Chul Koo; Byung Ha Chung
Journal:  Int Urol Nephrol       Date:  2017-09-13       Impact factor: 2.370

8.  Impact of a family history of prostate cancer on clinicopathologic outcomes and survival following radical prostatectomy.

Authors:  Mary E Westerman; Boris Gershman; R Jeffrey Karnes; R Houston Thompson; Laureano Rangel; Stephen A Boorjian
Journal:  World J Urol       Date:  2015-12-09       Impact factor: 4.226

9.  Associations of high-grade prostate cancer with BRCA1 and BRCA2 founder mutations.

Authors:  Ilir Agalliu; Robert Gern; Suzanne Leanza; Robert D Burk
Journal:  Clin Cancer Res       Date:  2009-02-01       Impact factor: 12.531

10.  Familial clustering of breast and prostate cancer and risk of postmenopausal breast cancer in the Women's Health Initiative Study.

Authors:  Jennifer L Beebe-Dimmer; Cecilia Yee; Michele L Cote; Nancie Petrucelli; Nynikka Palmer; Cathryn Bock; Dorothy Lane; Ilir Agalliu; Marcia L Stefanick; Michael S Simon
Journal:  Cancer       Date:  2015-03-09       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.